UK consumers purchased fewer groceries and alcoholic beverages during the Christmas period, with industry experts attributing the decline to the popularity of weight loss injections. Despite total grocery sales reaching £19.6 billion in the four weeks leading up to December 27, marking a 2.5% increase from the previous year according to NielsenIQ, sales volume experienced a slight decrease of 0.2%.
Analysts speculate that the connection lies in the growing use of GLP-1 injections, which replicate a hormone that induces early satiety in the body. These injections, including Mounjaro and Wegovy for weight loss and Ozempic for diabetes, have seen significant uptake among UK adults, with an estimated 1.6 million users in the past year according to recent research from University College London.
Retail experts noted a notable impact on high-calorie categories such as snacks and alcohol, as consumers embracing the “less but better” consumption shift associated with GLP-1 usage. Jonathan De Mello, a retail analyst at JDM Retail, highlighted the trend’s influence on grocery volumes, emphasizing the need for retailers to adapt their product offerings accordingly.
In response to changing consumer habits, major retailers like Co-op, Marks & Spencer, and Iceland have introduced new meal options tailored to evolving preferences for smaller portions and nutrient-dense choices. The shift towards more health-conscious eating patterns has also been acknowledged by industry leaders like Greggs, whose CEO Roisin Currie emphasized the importance of offering a diverse range of options to cater to customer demands.
As the impact of weight loss medication continues to shape consumer behavior, supermarket CEOs like Tesco’s Ken Murphy and Sainsbury’s Simon Roberts are closely monitoring market trends to align their strategies with evolving shopping habits. The industry’s response underscores a growing awareness of the influence of health and wellness considerations on purchasing decisions.